Exploring the frontier of cardiovascular pharmacotherapy-Reference-Cited by-同舟云学术

Exploring the frontier of cardiovascular pharmacotherapy

Published:2021-12 Issue:12 Volume:41 Page:968-969
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Baker William L.¹^ORCID,Jackevicius Cynthia A.²³⁴⁵^ORCID

Affiliation:

1. University of Connecticut School of Pharmacy Storrs Connecticut USA

2. College of Pharmacy Western University of Health Sciences Pomona California USA

3. VA Greater Los Angeles Healthcare System Los Angeles California USA

4. Institute of Health Policy Management, and Evaluation University of Toronto Toronto Ontario Canada

5. ICES Toronto Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2645

Reference14 articles.

1. Heart Disease and Stroke Statistics—2021 Update

2. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Arnett DK;Circulation,2019

3. 2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

4. Meta‐analysis of clinical outcomes of PCSK9 Modulators in patients with established ASCVD;Talasaz AH;Pharmacotherapy,2021

5. Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease;Barry A;Pharmacotherapy,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical Infection Society Guidance for Restoration of Surgical Services during the Coronavirus Disease-2019 Pandemic;Surgical Infections;2021-10-01